These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24516992)

  • 1. Evaluating the bioactive effects of flavonoid hesperidin--a new literature data survey.
    Kuntić V; Brborić J; Holclajtner-Antunović I; Uskoković-Marković S
    Vojnosanit Pregl; 2014 Jan; 71(1):60-5. PubMed ID: 24516992
    [No Abstract]   [Full Text] [Related]  

  • 2. Editor's presentation.
    Piepoli MF
    Eur J Prev Cardiol; 2018 Jul; 25(11):1123-1125. PubMed ID: 30035636
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular risk assessment and lipid modification: NICE guideline.
    Duerden M; O'Flynn N; Qureshi N
    Br J Gen Pract; 2015 Jul; 65(636):378-80. PubMed ID: 26120133
    [No Abstract]   [Full Text] [Related]  

  • 4. Atrium.
    Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):437-438. PubMed ID: 31133229
    [No Abstract]   [Full Text] [Related]  

  • 5. An appeal for reimbursement for innovative prevention measures in patient cardiovascular education.
    Frohlich ED
    Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):175. PubMed ID: 18368009
    [No Abstract]   [Full Text] [Related]  

  • 6. Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.
    Thomas H; Diamond J; Vieco A; Chaudhuri S; Shinnar E; Cromer S; Perel P; Mensah GA; Narula J; Johnson CO; Roth GA; Moran AE
    Glob Heart; 2018 Sep; 13(3):143-163. PubMed ID: 30301680
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary Prevention in LMIC: From Population-Based Surveys to Risk Factor Interventions.
    Moran AE; Narula J
    Glob Heart; 2017 Sep; 12(3):177-178. PubMed ID: 29092759
    [No Abstract]   [Full Text] [Related]  

  • 8. Editor's presentation.
    Piepoli MF
    Eur J Prev Cardiol; 2018 Mar; 25(4):339-341. PubMed ID: 29446663
    [No Abstract]   [Full Text] [Related]  

  • 9. By Jove! What is a clinician to make of JUPITER?
    Kaul S; Morrissey RP; Diamond GA
    Arch Intern Med; 2010 Jun; 170(12):1073-7. PubMed ID: 20585074
    [No Abstract]   [Full Text] [Related]  

  • 10. The 2000-2016 WHF Global Atlas of CVD: Take Two.
    Moran AE; Wood DA; Narula J
    Glob Heart; 2018 Sep; 13(3):139-141. PubMed ID: 30360786
    [No Abstract]   [Full Text] [Related]  

  • 11. Concurrent Validity of the Historical Leisure-time Physical Activity Question of the Spanish National Health Survey in Older Adults.
    Martínez-Gómez D; Guallar-Castillón P; Higueras-Fresnillo S; Rodríguez-Artalejo F
    Rev Esp Cardiol (Engl Ed); 2017 Aug; 70(8):669-670. PubMed ID: 27789171
    [No Abstract]   [Full Text] [Related]  

  • 12. The Road to 25×25: Update on WHF CVD Roadmaps.
    Grainger-Gasser A; Perel P; Lagier-Hässig L; Wood D
    Glob Heart; 2017 Sep; 12(3):269-270. PubMed ID: 27720665
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases.
    Roohbakhsh A; Parhiz H; Soltani F; Rezaee R; Iranshahi M
    Life Sci; 2015 Mar; 124():64-74. PubMed ID: 25625242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Hesperidin in Cell Signal Transduction Pathway for the Prevention or Treatment of Cancer.
    Ahmadi A; Shadboorestan A; Nabavi SF; Setzer WN; Nabavi SM
    Curr Med Chem; 2015; 22(30):3462-71. PubMed ID: 26502950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking Action for Cardiovascular Health Around the Globe: World Heart Day 2017.
    Mensah GA
    Glob Heart; 2017 Sep; 12(3):259-263. PubMed ID: 28969925
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasting or Nonfasting Lipid Measurements: It Depends on the Question.
    Driver SL; Martin SS; Gluckman TJ; Clary JM; Blumenthal RS; Stone NJ
    J Am Coll Cardiol; 2016 Mar; 67(10):1227-1234. PubMed ID: 26965545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cardiovascular disease prevention: time to get serious.
    Beaglehole R
    Lancet; 2001 Aug; 358(9282):661-3. PubMed ID: 11530175
    [No Abstract]   [Full Text] [Related]  

  • 18. [For an active prevention of cardiovascular diseases].
    Fabrégas B
    Soins; 2003; (672):14-5. PubMed ID: 12655817
    [No Abstract]   [Full Text] [Related]  

  • 19. Exercise as the master polypill of the 21st century for the prevention of cardiovascular disease.
    Sanchis-Gomar F; Fiuza-Luces C; Lucia A
    Int J Cardiol; 2015 Feb; 181():360-1. PubMed ID: 25555280
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beyond risk factors: priorities and new challenges of cardiovascular prevention].
    Urbinati S; Giampaoli S
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):7S-14S. PubMed ID: 20879472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.